Clinical Trial Update: Sitagliptin in Cystic Fibrosis-Related Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating sitagliptin for cystic fibrosis-related diabetes has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Cystic Fibrosis-related Diabetes

Drugs mentioned

• Sitagliptin (sitagliptin)

Snippet

Sponsor: University of British Columbia | Conditions: Cystic Fibrosis | Phase 2 | Status: TERMINATED